Trials / Completed
CompletedNCT01565369
Evaluation of Physician Training Methods to Read Florbetapir-PET Scans
Evaluation of Physician Training for Interpretation of Florbetapir-PET Scans: Validation of Binary Image Rating Methodology Using Amyloid Histopathology at Autopsy as the Reference Standard.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is re-read of brain amyloid positron emission tomography (PET) scans acquired in previous florbetapir F 18 clinical studies by readers trained using updated reading methodology. The scans in this study came from subjects who had an autopsy to reveal the subject's true amyloid status.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | florbetapir F 18 | IV injection, 370MBq (10mCi), single dose |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2012-03-28
- Last updated
- 2012-06-07
- Results posted
- 2012-06-07
Source: ClinicalTrials.gov record NCT01565369. Inclusion in this directory is not an endorsement.